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Impact of a Protocol Implementation on Identification and
Referral of Women At-Risk for Hereditary Breast Cancer
Chrysanthemum Davis Lawson
MSN, APRN, CNS, FNP-C, DNP Student
Significance of Problem
►Breast cancer is the leading new cancer diagnosis & 2nd highest
cause of cancer death in American women (American Cancer
Society, 2020)

►Hereditary breast cancer is often caused by mutations in the
BRCA 1 or 2 genes, with an associated 5 to 10-fold increase in
breast cancer risk (Mayo Clinic, 2019)
►10% of individuals with a gene mutation are aware of this
diagnosis (Drohan et al., 2012)
►The USPSTF issued a Grade B recommendation & advised use of
a risk assessment tool for identifying women at high-risk, so
appropriate referrals can be provided (Nelson et al., 2019)

PICOT Question
In women cared for in an obstetrical & gynecological practice (P) how
does utilization of a breast cancer genetics referral screening tool (I)
as compared to the current standard of care of collecting & reviewing
family history in patients’ EMR (C) allow women at increased risk for
hereditary breast cancer to be appropriately identified and referred for
genetic counseling (O) within a twelve-week time frame (T)?

Review of Literature
Search Terms: (1) “breast neoplasm” or “breast cancer” and
(2) “family history” or genetic or hereditary or “high risk” or inherited or
predisposition and (3) apprais* or “risk assessment” or tool* and
(4) refer*
Inclusion Criteria: English, female, published 2012-2019, academic
journal, scholarly/peer reviewed
Exclusion Criteria: Only women with history of breast cancer, breast
cancer tumor gene testing, breast cancer risk perception, risk tool
used during mammography for ordering MRIs, chemoprevention
Accepted: 10 pieces of evidence were appraised (829 yielded from 6
databases, 100 reviewed, 10 duplicates)

Synthesis of Evidence

The Evidence Level and Quality guide from the Johns Hopkins Nursing EvidenceBased Practice was used to appraise the evidence (Dang & Dearholt, 2017)

Decision to Change Practice
►Breast Cancer Genetics Referral Screening Tool (B-RST™) received
a high quality rating by USPSTF for assessing hereditary breast
cancer risk (Nelson et al., 2019)

Evaluation
Assessment Results

Referral Comparison

►B-RST™ Version 3.1 can be integrated in the EMR, has documented
ease of use, & covers 1st & 2nd degree family history of breast &
ovarian cancers, male breast cancer, & Ashkenazi Jewish heritage
(Belcross et al., 2019)

►Offering medical management options to this at-risk group can
promote breast cancer prevention or early detection to positively
affect health outcomes (ACOG, 2019; Kiely & Schwartz, 2014)

Implementation
►Setting: Ob/Gyn practice with 5 offices in a Midwestern state
►Providers: 9 total, included 3 each of CNMs, NPs, and physicians
►Time Frame: 12 weeks
►Inclusion Criteria: > 18 y/o, routine gyne exam or new patient appt
►Exclusion Criteria: < 18 y/o, impaired mental capacity (dementia,
mental retardation), appointment type other than those listed above,
previously performed
►Procedure: B-RST™ assessment performed by medical assistants
(MAs) & reviewed by the provider with referrals ordered accordingly
►EBP Protocol: Management advised for B-RST™ results:
(1) NEGATIVE-AVERAGE RISK – monthly breast self
examination & mammogram at appropriate age & interval
(2) NEGATIVE-MODERATE RISK – as above & referral
to the High Risk Breast Clinic (HRBC)
(3) POSITIVE-HIGH RISK – as above & referral to genetics
►Data Collection: Entering B-RST™ results in EMR, reviewing EMR
populated reports, & performing EMR chart audits
►Pre-implementation Group: Demographics & total referrals to
HRBC & genetics for patients meeting inclusion criteria as above
(N = 880) for the same 12-week time period one year prior were
obtained for comparison
►EBP Model: Iowa Model’s 7 steps guided this EBP project (2017)

Primary Outcomes:
1. Identify women at-risk
2. Refer women at-risk

Secondary Outcomes:
1. HRBC referral performance
2. Genetics referral performance

►Eligible: N = 1253
►Screened: n = 994
►Overall Protocol Adherence:
79.3% - achieved goal of ≥ 75%
►HRBC Candidates: n = 249
►Genetics Candidates: n = 174
►HRBC Referrals
Provided: n = 57, 22.9%
►Genetics Referrals
Provided: n = 32, 8.4%

►HRBC Consultation
Completed: n = 8 (14.0%)
►Genetic Consultation
Completed: n = 7 (21.9%)
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►HRBC Total Referrals Pre- to
Post-Implementation: 51
►Genetics Total Referrals Preto Post-Implementation:  24

Referral Performance Results

Statistical Analyses
►Chi-Square Test for
Independence: Pre- & postimplementation group demographic
variables were independent,
indicating sampling representative
of office population for age, appt
type, insurance, race, & religion
► Factorial ANOVA: Significant
effects with increases in referrals to
HRBC & genetics with providers
using the B-RST™ to guide
decision-making

Group = Pre- or Post-Implementation
Statistical significance at p < .05

Conclusion
►Use of the B-RST™ was an effective method at an Ob/Gyn office
setting for identifying & providing referrals to women at-risk for
hereditary breast cancer
►Continued B-RST™ use & improved participant referral performance
necessary to support overall goal of medical management for
promoting optimal health outcomes

Recommendations
►EBP Project Site: (1) Perform B-RST™ once yearly for all patients,
(2) Improve referral provision rates & document if HRBC &/or
genetics referrals were offered, accepted, &/or declined, & (3)
Provide patient reported reasons for a referral being declined to aid in
improving participation rates
►Health Care Community: (1) Educate nursing/APRN/PA/medical
students & health care providers about hereditary breast cancer risk
& use of the B-RST™ & (2) Recognize & address barriers for
providers ordering referrals & patients performing these consultations

